온코크로스

382150KOSDAQ자연과학 및 공학 연구개발업

47.3 / 100

Reference Date: 2026-07-24

Financial Score13.0 / 40

News Sentiment21.3 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: the high debt ratio poses financial risk, Operating Profit is on a declining trend. Declined 13.4% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

OncoCross is a company that enhances drug development efficiency through its AI platform 'RAPTOR AI', which matches optimal diseases with therapies based on gene expression and protein data. It is also developing 'RAPTOR AI v2.0' to analyze next-generation modalities like ADC and TPD, and expanding its B2B market through the 'Neo Omics' service.

Number of Employees

40people

Average Salary

75.3M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 43.644.0Point

PBR

3.07Industry Average 2.522.5Point

Higher than industry avg (caution)

ROE

-52.79Industry Average -32.093.5Point

1.6x industry avg (good)

Debt Ratio

73.51Industry Average 7.310.0Point

10.1x industry avg (risky)

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲503.0% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼14.5% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -42.6% (declining, 3yr)

Detailed News Sentiment

5 totalPositive 5Neutral 0Negative 0Average Sentiment Score 85

Positive
AI가 암을 먼저 찾아낸다…한국, 신약개발로 승부수
온코크로스의 AI 기반 암 진단 기술이 글로벌 시장 전망에서 긍정적인 평가를 받으며 기업 가치 상승 기대.
Positive
클립스비엔씨, 온코크로스와 임상시험 최적화 위한 AI 활용 협력체계.....
온코크로스와 클립스비엔씨의 협력으로 임상시험 효율성이 크게 향상될 것으로 예상되어 관련 주식에 긍정적 영향.
Positive
온코크로스, 온코마스터 합병완료…환자데이터 기반 플랫폼 사업 본격...
온코크로스의 온코마스터 합병 완료로 암환자 데이터 기반 AI 플랫폼 구축이 본격화되어 기업 성장 잠재력이 높아졌다.

Detailed Momentum

52-week position1.0Point

Near 52w low (2%, downtrend)

Current 3,370Won52-week high 13,87052-week low 3,065

1-month return1.0Point

1m -13.37% (falling)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0

Neutral[기재정정]분기보고서 (2026.03)2026-07-20
Neutral[기재정정]사업보고서 (2025.12)2026-07-16
Neutral주식등의대량보유상황보고서(약식)2026-07-10
Neutral합병등종료보고서(합병)2026-07-01